#
Problem
What the solver must do
How the answer is checked
Who benefits
01
Design organ-specific AAV capsid variants end-to-end from public sequence–function data.
Unseen variants under a strictly isolated hold-out.
Gene-therapy developers
02
Design and optimize pretrain / midtrain / posttrain recipes — architecture, optimizer,
schedule, RL, distillation — under a compute constraint.
Must beat expert-tuned baselines at matched compute.
Frontier and enterprise model builders
03
Discover, filter, construct and decontaminate training and benchmark data at scale, under
budget and throughput limits.
Downstream quality at fixed budget; contamination measurably removed.
Frontier and enterprise model builders
04
Build and verify reliable, high-throughput training and serving infrastructure across
models and hardware.
Bit-exact reproduction and measured throughput across targets.
Model builders; compute providers
05
Rank repurposing candidates for a target disease using only evidence visible before a
cutoff.
Enrichment of the top-K against post-cutoff clinical and real-world success.
Pharma; biotech; disease foundations
06
Generate SAP-faithful trial analysis code and top-line tables, listings and figures.
Cell-level audit lineage back to the protocol; fidelity to the statistical analysis plan.
Pharma biostatistics; CROs
07
Clinical trial safety & efficacy signal detection
Healthcare & Life Sciences
Auto-generate and stress-test safety and efficacy hypotheses from accruing trial data.
Signals validated against post-cutoff outcomes.
Pharma; medical monitors; CROs
08
Causal drug-target validation
Healthcare & Life Sciences
Decide whether a candidate gene target is a causal driver or an associated passenger, and
name the falsifying experiment.
Held-out genetics and perturbation outcomes; known target successes and failures.
Pharma discovery; biotech
09
Non-consensus investment thesis generation
Financial Services
Surface overlooked evidence, non-consensus theses, and bull / base / bear scenarios for
deep-tech decisions.
Historical time-split replay, shadow portfolio, out-of-sample thesis tracking.
Asset managers; venture and growth investors
10
Crop yield shortfall forecasting
Agriculture & Food
Predict localised crop-yield shortfalls sixty days ahead of official reports, from
satellite, soil and climate data.
The official report, when it lands.
Agricultural traders; food processors; insurers
11
Code-compliant structural design
Real Estate & Construction
Generate structural and foundation layouts from a floor plan, minimising embodied carbon
under seismic constraints.
Automated code-compliance check; carbon and seismic constraints evaluated.
Engineering and design firms; developers
12
Cell therapy manufacturing optimization
Healthcare & Life Sciences
Optimize per-batch manufacturing parameters to raise potency and post-infusion
persistence.
Measured batch potency and persistence after infusion.
Cell-therapy manufacturers; CDMOs
13
Biological age & mortality risk prediction
Healthcare & Life Sciences
Estimate biological age and mortality risk from multimodal health data — records,
imaging, labs.
Unseen held-out cohorts.
Health systems; insurers; longevity clinics
14
iPSC-cardiomyocyte differentiation modeling
Healthcare & Life Sciences
Model iPSC-to-cardiomyocyte differentiation trajectories and the effect of disease
mutations.
Unseen donors and unseen mutations.
Cardiac drug discovery; academic labs
15
Rare disease diagnosis from whole-genome data
Healthcare & Life Sciences
Produce structured diagnostic reports from raw whole-genome or whole-exome data and match
patients to trial eligibility.
Confirmed diagnoses; eligibility verified against trial criteria.
Rare-disease centres; patient organisations
16
Metabolic treatment response prediction
Healthcare & Life Sciences
Predict response and non-response, and rank the best twelve-month interventions per
patient.
Twelve-month weight, HbA1c, discontinuation and rebound outcomes.
Payers; health systems; pharma
17
Preclinical-to-human translation prediction
Healthcare & Life Sciences
Predict whether a preclinical result will translate, and attribute the cross-species
causal gap when it does not.
Paired preclinical and human outcomes on held-out drugs.
Pharma R&D; biotech
18
Near-term health deterioration prediction
Healthcare & Life Sciences
Predict near-term health decline from longitudinal personal data and recommend safe next
actions.
Observed near-term decline and escalation outcomes.
Health systems; payers; care providers
19
Work-state reconstruction & open-loop detection
Software & Internet
Reconstruct active work state across a company's tools and detect unresolved commitments,
decisions and risks.
Whether flagged items were genuinely open, and whether the loop closed.
Enterprises
20
Material-event detection from real-time news
Software & Internet
Monitor real-time signals for events that materially change a user's world model, with
alternative readings.
Whether flagged events proved material, judged after the fact.
Enterprises; investors; analysts